794 related articles for article (PubMed ID: 11602409)
21. Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.
Soenen-Cornu V; Tourino C; Bonnet ML; Guillier M; Flamant S; Kotb R; Bernheim A; Bourhis JH; Preudhomme C; Fenaux P; Turhan AG
Oncogene; 2005 Apr; 24(15):2441-8. PubMed ID: 15735749
[TBL] [Abstract][Full Text] [Related]
22. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
23. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome.
Flores-Figueroa E; Gutiérrez-Espíndola G; Montesinos JJ; Arana-Trejo RM; Mayani H
Leuk Res; 2002 Jul; 26(7):677-86. PubMed ID: 12008086
[TBL] [Abstract][Full Text] [Related]
25. Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells.
Schwartz GN; Warren MK; Rothwell SW; Zujewski J; Halverson DC; Cowan KH; Tolcher A; O'Shaughnessy J; Gress RE
Bone Marrow Transplant; 1998 Sep; 22(5):457-68. PubMed ID: 9733269
[TBL] [Abstract][Full Text] [Related]
26. Increased longevity of hematopoiesis in continuous bone marrow cultures derived from NOS1 (nNOS, mtNOS) homozygous recombinant negative mice correlates with radioresistance of hematopoietic and marrow stromal cells.
Epperly MW; Cao S; Zhang X; Franicola D; Shen H; Greenberger EE; Epperly LD; Greenberger JS
Exp Hematol; 2007 Jan; 35(1):137-45. PubMed ID: 17198882
[TBL] [Abstract][Full Text] [Related]
27. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
Pyrovolaki K; Mavroudi I; Sidiropoulos P; Eliopoulos AG; Boumpas DT; Papadaki HA
Arthritis Rheum; 2009 Feb; 60(2):543-52. PubMed ID: 19180486
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic analysis of myelodysplastic syndromes.
Del Cañizo MC; Fernández ME; López A; Vidriales B; Villarón E; Arroyo JL; Ortuño F; Orfao A; San Miguel JF
Haematologica; 2003 Apr; 88(4):402-7. PubMed ID: 12681967
[TBL] [Abstract][Full Text] [Related]
30. Stromal cells negatively regulate primitive haemopoietic progenitor cell activation via a phosphatidylinositol-anchored cell adhesion/signalling mechanism.
Gordon MY; Lewis JL; Marley SB; Grand FH; Goldman JM
Br J Haematol; 1997 Mar; 96(3):647-53. PubMed ID: 9054678
[TBL] [Abstract][Full Text] [Related]
31. The geldanamycin derivative 17-AAG decreases VEGF secretion and leukemia growth support by trisomy 8 myelodysplastic syndrome bone marrow stromal cells.
Hawkins LM; Narendran A
Pediatr Hematol Oncol; 2005 Mar; 22(2):115-25. PubMed ID: 15804996
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders.
Yoon SY; Tefferi A; Li CY
Haematologica; 2001 Jan; 86(1):52-7. PubMed ID: 11146571
[TBL] [Abstract][Full Text] [Related]
33. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
Van Overstraeten-Schlögel N; Beguin Y; Gothot A
Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
[TBL] [Abstract][Full Text] [Related]
34. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
Ribeiro E; Matarraz Sudón S; de Santiago M; Lima CS; Metze K; Giralt M; Saad ST; de Matos AO; Lorand-Metze I
Leuk Res; 2006 Jan; 30(1):9-16. PubMed ID: 16005514
[TBL] [Abstract][Full Text] [Related]
35. Control of stroma-dependent hematopoiesis by basic fibroblast growth factor: stromal phenotypic plasticity and modified myelopoietic functions.
Sternberg D; Peled A; Shezen E; Abramsky O; Jiang W; Bertolero F; Zipori D
Cytokines Mol Ther; 1996 Mar; 2(1):29-38. PubMed ID: 9384687
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor.
Matsuda-Hashii Y; Takai K; Ohta H; Fujisaki H; Tokimasa S; Osugi Y; Ozono K; Matsumoto K; Nakamura T; Hara J
Exp Hematol; 2004 Oct; 32(10):955-61. PubMed ID: 15504551
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive therapy in bone marrow aplasia: the stroma functions normally to support hematopoiesis.
Novitzky N; Jacobs P
Exp Hematol; 1995 Dec; 23(14):1472-7. PubMed ID: 8542933
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
[TBL] [Abstract][Full Text] [Related]
39. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R
Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
[TBL] [Abstract][Full Text] [Related]
40. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
